{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:23:58Z","timestamp":1793877838125,"version":"4.7.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["NO. 2017YFC1001200"],"award-info":[{"award-number":["NO. 2017YFC1001200"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO. 81671433 (MJL)"],"award-info":[{"award-number":["NO. 81671433 (MJL)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>T cell immunoglobulin and mucin domain-containing molecule-3 (TIM-3) initially discovered on the surface of Th1 cells, negatively regulates immune responses and mediates apoptosis of Th1 cells. An increasing number of studies have since shown that TIM-3 is crucial in the genesis and development of immune diseases, cancers, and chronic infectious illnesses. However, the effect of TIM-3 on endometriosis is still unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Quantitative real-time polymerase chain reaction, western blotting, and immunohistochemistry were used to measure TIM-3 levels in endometriosis. Cell Counting Kit-8, 5-ethynyl-2\u2019-deoxyuridine, colony-forming, Transwell\u00ae migration, Matrigel\u00ae invasion, and flow cytometry assays were used to explore the function of TIM-3 in vitro, and xenograft experiments in nude mice were used to assess its role in vivo. According to the RNA seq, brain-derived neurotrophic factor (BDNF) was screened. The involvement of specific proliferation-related signaling molecules was determined by transfecting a plasmid and adding an inhibitor in vivo and in vitro.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>TIM-3 mRNA and protein expression levels were significantly higher in eutopic and ectopic endometrial tissues than in normal endometrial tissues. By examining the effects of TIM-3 overexpression and knockdown on cell proliferation, migration, and invasion in vitro, and lesions formation in vivo, we found that the expression of TIM-3 was positively correlated with cell proliferation and clone formation in vitro, as well as lesions growth in nude mice. By adding the phosphatidylinositol 3 kinase\/protein kinase B(PI3K\/AKT) pathway inhibitor LY294002 and knocking down PI3K, we further verified that TIM-3 promotes proliferation in vivo and in vitro via the PI3K pathway. By transfecting the plasmid into ESC cells and gave inhibitors to endometriotic rats models, we tested that TIM-3 regulates the proliferation by BDNF-mediated PI3K\/AKT axis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>TIM-3 can promote the proliferation of endometriosis by BDNF-mediated PI3K\/AKT axis in vivo and in vitro, which may provide a new therapeutic target for the treatment of endometriosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10020-023-00768-6","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T13:01:58Z","timestamp":1702990918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["TIM-3 regulates the proliferation by BDNF-mediated PI3K\/AKT axis in the process of endometriosis"],"prefix":"10.1186","volume":"29","author":[{"given":"Wei","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HuaFeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8027-6319","authenticated-orcid":false,"given":"Mingjiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"key":"768_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1744-8069-10-28","volume":"10","author":"Y Bao","year":"2014","unstructured":"Bao Y, Hou W, Liu R, Gao Y, Kong X, Yang L, Shi Z, Li W, Zheng H, Jiang S, Li C, Qin Y, Hua B. PAR2-mediated upregulation of BDNF contributes to central sensitization in Bone cancer pain. Mol Pain. 2014;10:28. https:\/\/doi.org\/10.1186\/1744-8069-10-28.","journal-title":"Mol Pain"},{"key":"768_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0053834","volume":"8","author":"Y Cao","year":"2013","unstructured":"Cao Y, Zhou X, Huang X, et al. Tim-3 expression in Cervical cancer promotes Tumor Metastasis. PLoS ONE. 2013;8:1\u20138. https:\/\/doi.org\/10.1371\/journal.pone.0053834.","journal-title":"PLoS ONE"},{"issue":"3","key":"768_CR31","doi-asserted-by":"publisher","first-page":"e0152830","DOI":"10.1371\/journal.pone.0152830","volume":"11","author":"Y Cao","year":"2016","unstructured":"Cao Y, Zhou X, Huang X, Li Q, Gao L, Jiang L, Huang M, Zhou J. Correction: Tim-3 expression in Cervical Cancer promotes Tumor Metastasis. PLoS ONE. 2016;11(3):e0152830. https:\/\/doi.org\/10.1371\/journal.pone.0152830.","journal-title":"PLoS ONE"},{"issue":"4","key":"768_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrn1078","volume":"4","author":"MV Chao","year":"2003","unstructured":"Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci. 2003;4(4):299\u2013309. https:\/\/doi.org\/10.1038\/nrn1078.","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"768_CR40","doi-asserted-by":"publisher","first-page":"C863","DOI":"10.1152\/ajpcell.00272.2018","volume":"315","author":"Q Chen","year":"2018","unstructured":"Chen Q, Hang Y, Zhang T, Tan L, Li S, Jin Y. USP10 promotes proliferation and migration and inhibits apoptosis of endometrial stromal cells in endometriosis through activating the Raf-1\/MEK\/ERK pathway. Am J Physiol Cell Physiol. 2018;315(6):C863\u201372. https:\/\/doi.org\/10.1152\/ajpcell.00272.2018.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"7\u20138","key":"768_CR39","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00018-005-5490-8","volume":"63","author":"CJ Desmet","year":"2006","unstructured":"Desmet CJ, Peeper DS. The neurotrophic receptor TrkB: a drug target in anti-cancer therapy? Cell Mol Life Sci. 2006;63(7\u20138):755\u20139. https:\/\/doi.org\/10.1007\/s00018-005-5490-8.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"768_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/QAI.0b013e318285cf13","volume":"63","author":"CA Finney","year":"2013","unstructured":"Finney CA, et al. HIV Infection deregulates Tim-3 expression on innate cells: combination antiretroviral therapy results in partial restoration. J Acquir Immune Defic Syndr. 2013;63(2):161\u20137. https:\/\/doi.org\/10.1097\/QAI.0b013e318285cf13.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"768_CR41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s43032-020-00301-8","volume":"28","author":"X Fu","year":"2021","unstructured":"Fu X, Yao M, Ye C, Fang T, Wu R. Osteopontin regulates endometrial stromal cell Migration in Endometriosis through the PI3K pathway: Osteopontin regulates Endometrial Cell Migration in Endometriosis. Reproductive Sci (Thousand Oaks Calif). 2021;28(2):435\u201346. https:\/\/doi.org\/10.1007\/s43032-020-00301-8.","journal-title":"Reproductive Sci (Thousand Oaks Calif)"},{"key":"768_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0030676","volume":"7","author":"X Gao","year":"2012","unstructured":"Gao X, Zhu Y, Li G, et al. TIM-3 expression characterizes regulatory T cells in Tumor tissues and is associated with Lung cancer progression. PLoS ONE. 2012;7:1\u20138. https:\/\/doi.org\/10.1371\/journal.pone.0030676.","journal-title":"PLoS ONE"},{"key":"768_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1084\/jem.20090397","volume":"207","author":"X Huang","year":"2010","unstructured":"Huang X, Bai X, Cao Y, et al. Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of Lymphoma by mediating immune evasion. J Exp Med. 2010;207:505\u201320. https:\/\/doi.org\/10.1084\/jem.20090397.","journal-title":"J Exp Med"},{"key":"768_CR13","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1073\/pnas.1100551108","volume":"108","author":"M Jan","year":"2011","unstructured":"Jan M, Chao MP, Cha AC, Alizadeh AA, Gentles AJ, Weissman IL, Majeti R. Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute Myeloid Leukemia stem cell marker. Proc Natl Acad Sci USA. 2011;108:5009\u201314. https:\/\/doi.org\/10.1073\/pnas.1100551108.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"768_CR9","doi-asserted-by":"publisher","first-page":"e81799","DOI":"10.1371\/journal.pone.0081799","volume":"8","author":"J Jiang","year":"2013","unstructured":"Jiang J, Jin MS, Kong F, et al. Decreased Galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancer. PLoS ONE. 2013;8(12):e81799. https:\/\/doi.org\/10.1371\/journal.pone.0081799.","journal-title":"PLoS ONE"},{"issue":"9","key":"768_CR22","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1182\/blood-2008-02-142596","volume":"113","author":"J Klibi","year":"2009","unstructured":"Klibi J, et al. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood. 2009;113(9):1957\u201366. https:\/\/doi.org\/10.1182\/blood-2008-02-142596.","journal-title":"Blood"},{"key":"768_CR15","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1158\/2326-6066.CIR-14-0156","volume":"3","author":"Y Komohara","year":"2015","unstructured":"Komohara Y, Morita T, Annan DA, et al. The coordinated actions of TIM-3 on cancer and myeloid cells in the regulation of tumorigenicity and clinical prognosis in clear cell renal cell carcinomas. Cancer Immunol Res. 2015;3:999\u20131007. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0156.","journal-title":"Cancer Immunol Res"},{"key":"768_CR2","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.3390\/ijms20225615","volume":"20","author":"AS Lagan\u00e0","year":"2019","unstructured":"Lagan\u00e0 AS, Garzon S, G\u00f6tte M, Vigan\u00f2 P, Franchi M, Ghezzi F, Martin DC. The pathogenesis of endometriosis: Molecular and Cell Biology insights. Int J Mol Sci. 2019;20:5615. https:\/\/doi.org\/10.3390\/ijms20225615.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"768_CR34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0959-4388(00)00209-9","volume":"11","author":"FS Lee","year":"2001","unstructured":"Lee FS, Kim AH, Khursigara G, Chao MV. The uniqueness of being a neurotrophin receptor. Curr Opin Neurobiol. 2001;11(3):281\u20136. https:\/\/doi.org\/10.1016\/s0959-4388(00)00209-9.","journal-title":"Curr Opin Neurobiol"},{"key":"768_CR8","doi-asserted-by":"publisher","unstructured":"Lee J, Phong B, Egloff AM et al. TIM polymorphisms: genetic sand function[J].Gen es Immun, 2011a,12:595\u2013604. https:\/\/doi.org\/10.1038\/gene.2011.75.","DOI":"10.1038\/gene.2011.75"},{"issue":"5","key":"768_CR16","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3109\/03009742.2010.547871","volume":"40","author":"Lee","year":"2011","unstructured":"Lee, et al. Expression of human TIM-3 and its correlation with Disease activity in rheumatoid arthritis. Scand J Rheumatol. 2011b;40(5):334\u201340. https:\/\/doi.org\/10.3109\/03009742.2010.547871.","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"768_CR18","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/hep.25777","volume":"56","author":"H Li","year":"2012","unstructured":"Li H, et al. Tim-3\/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with Hepatitis B virus-associated hepatocellular carcinoma. Hepatology. 2012;56(4):1342\u201351. https:\/\/doi.org\/10.1002\/hep.25777.","journal-title":"Hepatology"},{"issue":"22","key":"768_CR4","doi-asserted-by":"publisher","first-page":"6008","DOI":"10.1093\/hmg\/ddu330","volume":"23","author":"X Li","year":"2014","unstructured":"Li X, Zhang Y, Zhao L, Wang L, Wu Z, Mei Q, et al. Whole exome sequencing of endometriosis identifies frequent alterations in genes involved in cell adhesion and chromatin-remodeling complexes. Hum Mol Genet. 2014;23(22):6008\u201321. https:\/\/doi.org\/10.1093\/hmg\/ddu330.","journal-title":"Hum Mol Genet"},{"key":"768_CR32","doi-asserted-by":"publisher","first-page":"42938","DOI":"10.1038\/srep42938","volume":"7","author":"P Li","year":"2017","unstructured":"Li P, Gan Y, Xu Y, Song L, Wang L, Ouyang B, Zhang C, Zhou Q. The inflammatory cytokine TNF-\u03b1 promotes the premature senescence of rat nucleus pulposus cells via the PI3K\/Akt signaling pathway. Sci Rep. 2017;7:42938. https:\/\/doi.org\/10.1038\/srep42938.","journal-title":"Sci Rep"},{"issue":"7","key":"768_CR36","doi-asserted-by":"publisher","first-page":"9087","DOI":"10.1096\/fj.201802159RRR","volume":"34","author":"T Li","year":"2020","unstructured":"Li T, Yu Y, Song Y, Li X, Lan D, Zhang P, Xiao Y, Xing Y. Activation of BDNF\/TrkB pathway promotes Prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology. 2020;34(7):9087\u2013101. https:\/\/doi.org\/10.1096\/fj.201802159RRR.","journal-title":"FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"5","key":"768_CR35","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1007\/s13277-015-4427-6","volume":"37","author":"J Long","year":"2016","unstructured":"Long J, Jiang C, Liu B, Fang S, Kuang M. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine. 2016;37(5):5821\u20138. https:\/\/doi.org\/10.1007\/s13277-015-4427-6.","journal-title":"Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"768_CR6","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/ni739","volume":"2","author":"JJ McIntire","year":"2001","unstructured":"McIntire JJ, Umetsu SE, Akbari O, et al. Identification of Tapr(an airway hyperreactivity regulatory locus) and the linked Tim Gene family. Nat Immunol. 2001;2:1109\u201316. https:\/\/doi.org\/10.1038\/ni739.","journal-title":"Nat Immunol"},{"key":"768_CR5","doi-asserted-by":"publisher","first-page":"110486","DOI":"10.1016\/j.mce.2019.110486","volume":"494","author":"X Meng","year":"2019","unstructured":"Meng X, Liu J, Wang H, Chen P, Wang D. MicroRNA-126-5p downregulates BCAR3 expression to promote cell migration and invasion in endometriosis. Mol Cell Endocrinol. 2019;494:110486. https:\/\/doi.org\/10.1016\/j.mce.2019.110486.","journal-title":"Mol Cell Endocrinol"},{"issue":"6871","key":"768_CR7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/415536a","volume":"415","author":"L Monney","year":"2002","unstructured":"Monney L, Sabatos CA, Gaglia JL, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease[J]. Nat (London). 2002;415(6871):536\u201341. https:\/\/doi.org\/10.1038\/415536a.","journal-title":"Nat (London)"},{"issue":"10","key":"768_CR20","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1158\/0008-5472.CAN-11-0096","volume":"71","author":"SF Ngiow","year":"2011","unstructured":"Ngiow SF, et al. Anti-TIM3 antibody promotes T cell IFN-gamma-mediated antitumor immunity and suppresses established tumors. Cancer Res. 2011;71(10):3540\u201351. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-0096.","journal-title":"Cancer Res"},{"key":"768_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1196\/annals.1434.007","volume":"1127","author":"S Ozkan","year":"2008","unstructured":"Ozkan S, Murk W, Arici A. Endometriosis and infertility: epidemiology and evidence-based treatments[J]. Ann N Y Acad Sci. 2008;1127:92\u2013100. https:\/\/doi.org\/10.1196\/annals.1434.007.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"768_CR23","doi-asserted-by":"publisher","first-page":"1889822","DOI":"10.1080\/2162402X.2021.1889822","volume":"10","author":"J Rakova","year":"2021","unstructured":"Rakova J, et al. TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients. Oncoimmunology. 2021;10(1):1889822. https:\/\/doi.org\/10.1080\/2162402X.2021.1889822.","journal-title":"Oncoimmunology"},{"issue":"6","key":"768_CR12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1158\/2326-6066.CIR-17-0708","volume":"6","author":"H Seo","year":"2018","unstructured":"Seo H, Kim BS, Bae EA, Min BS, Han YD, Shin SJ, Kang CY. IL21 therapy combined with PD-1 and Tim-3 Blockade provides enhanced NK Cell Antitumor activity against MHC class I-Deficient tumors. Cancer Immunol Res. 2018;6(6):685\u201395. https:\/\/doi.org\/10.1158\/2326-6066.CIR-17-0708.","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"768_CR27","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.3892\/or.2016.4938","volume":"36","author":"B Shan","year":"2016","unstructured":"Shan B, Man H, Liu J, Wang L, Zhu T, Ma M, Xv Z, Chen X, Yang X, Li P. TIM-3 promotes the Metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt\/GSK-3\u03b2\/Snail signaling pathway. Oncol Rep. 2016;36(3):1551\u201361. https:\/\/doi.org\/10.3892\/or.2016.4938.","journal-title":"Oncol Rep"},{"issue":"5","key":"768_CR37","doi-asserted-by":"publisher","first-page":"6428","DOI":"10.3892\/mmr.2017.7396","volume":"16","author":"D Song","year":"2017","unstructured":"Song D, Diao J, Yang Y, Chen Y. MicroRNA-382 inhibits cell proliferation and invasion of retinoblastoma by targeting BDNFmediated PI3K\/AKT signalling pathway. Mol Med Rep. 2017;16(5):6428\u201336. https:\/\/doi.org\/10.3892\/mmr.2017.7396.","journal-title":"Mol Med Rep"},{"issue":"1","key":"768_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4149\/neo_2017_112","volume":"64","author":"QY Sun","year":"2017","unstructured":"Sun QY, Qu CH, Liu JQ, Zhang P, Yao J. Down-regulated expression of Tim-3 promotes invasion and Metastasis of Colorectal cancer cells. Neoplasma. 2017;64(1):101\u20137. https:\/\/doi.org\/10.4149\/neo_2017_112.","journal-title":"Neoplasma"},{"key":"768_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/gene.2011.75","volume":"8","author":"J Tan","year":"2020","unstructured":"Tan J, et al. Increased PD-1\u2009+\u2009Tim-3\u2009+\u2009exhausted T cells in bone marrow may influence the clinical outcome of patients with AML. Biomark Res. 2020;8:6. https:\/\/doi.org\/10.1038\/gene.2011.75.","journal-title":"Biomark Res"},{"issue":"1","key":"768_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12958-021-00725-0","volume":"19","author":"X Tang","year":"2021","unstructured":"Tang X, Li Q, Li L, Jiang J. Expression of Talin-1 in endometriosis and its possible role in pathogenesis. Reprod Biol Endocrinol. 2021;19(1):42. https:\/\/doi.org\/10.1186\/s12958-021-00725-0.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"768_CR28","doi-asserted-by":"publisher","first-page":"8869","DOI":"10.1038\/s41598-017-09484-8","volume":"7","author":"J Wu","year":"2017","unstructured":"Wu J, Lin G, Zhu Y, Zhang H, Shi G, Shen Y, Zhu Y, Dai B, Ye D. Low TIM3 expression indicates poor prognosis of metastatic Prostate cancer and acts as an Independent predictor of castration resistant status. Sci Rep. 2017;7(1):8869. https:\/\/doi.org\/10.1038\/s41598-017-09484-8.","journal-title":"Sci Rep"},{"issue":"7","key":"768_CR17","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.4049\/jimmunol.180.7.4409","volume":"180","author":"L Yang","year":"2008","unstructured":"Yang L, et al. Lack of TIM-3 immunoregulation in multiple sclerosis. J Immunol. 2008;180(7):4409\u201314. https:\/\/doi.org\/10.4049\/jimmunol.180.7.4409.","journal-title":"J Immunol"},{"issue":"1","key":"768_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4149\/neo_2014_006","volume":"61","author":"J Yuan","year":"2014","unstructured":"Yuan J, Jiang B, Zhao H, Huang Q. Prognostic implication of TIM-3 in clear cell renal cell carcinoma. Neoplasma. 2014;61(1):35\u201340. https:\/\/pubmed.ncbi.nlm.nih.gov\/24195506\/.","journal-title":"Neoplasma"},{"key":"768_CR26","doi-asserted-by":"publisher","first-page":"31705","DOI":"10.18632\/oncotarget.15954","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Cai P, Liang T, et al. TIM-3 is a potential prognostic marker for patients with solid tumors: a systematic review and meta-analysis. Oncotarget. 2017;8:31705\u201313. https:\/\/doi.org\/10.18632\/oncotarget.15954.","journal-title":"Oncotarget"},{"issue":"4","key":"768_CR19","doi-asserted-by":"publisher","first-page":"e12825","DOI":"10.1111\/sji.12825","volume":"91","author":"L Zhao","year":"2020","unstructured":"Zhao L, et al. TIM-3: an emerging target in the Liver Diseases. Scand J Immunol. 2020;91(4):e12825. https:\/\/doi.org\/10.1111\/sji.12825.","journal-title":"Scand J Immunol"},{"key":"768_CR10","first-page":"8018","volume":"8","author":"E Zhou","year":"2015","unstructured":"Zhou E, Huang Q, Wang J, et al. Up-regulation of Tim-3 is associated with poor prognosis of patients with colon Cancer. Int J Clin Exp Pathol. 2015;8:8018\u201327. https:\/\/europepmc.org\/article\/MED\/26339368.","journal-title":"Int J Clin Exp Pathol"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00768-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-023-00768-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00768-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T01:07:15Z","timestamp":1703034435000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-023-00768-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["768"],"URL":"https:\/\/doi.org\/10.1186\/s10020-023-00768-6","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"assertion":[{"value":"13 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients submitted informed written consent to utilize biological specimens for investigational procedures, according to the Ethics Committee of Biomedical Research involving people in the Provincial Hospital of Shandong First Medical University (SWYX: NO.2022\u2009\u2212\u2009565). The animal experiments were approved by the Ethics Committee of experimental animal in the Provincial Hospital of Shandong First Medical University (NO.2021-068).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors consent to publication of the present manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}